First AD

Second AD

Oncology Business Management

 Oncology Business Management condition center page is a comprehensive resource for news and expert insights on business-focused updates and topics in oncology practices, including diversity efforts, telehealth, gaps in care, payment models, and more. This page features news articles, interviews in written and video format, and podcasts that focus on updates and best practices with oncology business management.

Biosimilars

 Biosimilars condition center page is a comprehensive resource for clinical news and expert insights on currently available and investigational biosimilars for reference drugs such as trastuzumab, rituximab, bevacizumab, and more. This page features news articles, interviews in written and video format, and podcasts that focus on updates with biosimilars and ongoing research with these types of agents.

Emergence of Biosimilars in Oncology

Peer Exchange

Pharmacovigilance Requirements for Biosimilar Products

An Overview of Biosimilarity

The Adoption and Choice of Biosimilars

Decision Makers for Formulary Approval of Biosimilars

Biosimilar Use in the Treatment of NSCLC

The Use of Biosimilars in HER2+ Breast Cancer

The Complexity of Choosing Biosimilars in Oncology

Evidence-Based Extrapolation for Biosimilars

Biosimilar Interchangeability in Practice

Educating Physicians When Prescribing Biosimilars

The Availability of Multiple Biosimilars for 1 Biologic

The Future Direction of Biosimilars